Global Transfection Reagents Market Overview:
With Advancements in the healthcare industry, it has been witnessed that transfection reagents played an important role in the study of gene function & regulation, mutational analysis and biochemical characterization of gene products. The Transfection reagents market has high growth prospects due to its high-efficiency, low-toxicity transfection in many cells. Additionally, the growing popularity of biopharmaceuticals and the ongoing development of drug delivery systems propelled the transfection reagents market. Moreover, a growing trend in the transfection reagents market has been witnessed with respect to the demand for advanced techniques such are stable and transient transfection expected to fuel the market growth during the forecasted period. According to AMA, the Global Transfection Reagents market is expected to see growth rate of 7.4% and may see market size of USD1358.9 Million by 2024.
- Increasing Incidence of Cancer Patients Globally
- Growing Research Activities in Cell Science.
- Upsurge Demand for Nano-Science Technology
- Value-Oriented Customers
- The rapid Progress of Cell and Gene Therapies Boost the Market
- High Cost Associated with Transfection Reagent.
- Stringent Restriction upon Sale of Commercial Kits
- Technological Advancements in Transfection Technology Such as Car-T, Crispr-Cas9 and Others.
- Rising in R&D Investments and Research Activities Boost the Pharmaceutical and Biotech Companies
- Threats of Cytotoxicity in Transfection.
- Transfection in Hard-to-Transfect Cells is Anticipated to Challenge the Market
In the Transfection Reagents market, it has been observed that most of the manufacturing companies are providing innovating solutions for the delivery of nucleic acids in research, bio-production, and therapeutics. It also involved in improving viability and morphology after transfection for more relevant data. They rely on strategies such as mergers & acquisitions, product development, geographical expansion, technological innovation and sourcing strategies to enhance their market share.
Some of the key players profiled in the report are Thermo Fisher Scientific Inc. (United States), Promega Corporation (United States), Hoffmann-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), Polyplus-transfection SA (France), Bio-Rad Laboratories (United States), Lonza Group (Switzerland), Sigma-Aldrich Corporation (United States), Mirus Bio LLC (United States) and MaxCyte Inc. (United States). Analyst at AdvanceMarketAnalytics see United States Players to retain maximum share of Global Transfection Reagents market by 2024. Considering Market by End Users, the sub-segment i.e. Academic & Research Institutes will boost the Transfection Reagents market. Considering Market by Method, the sub-segment i.e. Biochemical will boost the Transfection Reagents market.
In May 2018, Altogen Biosystems launched a cGMP-grade nanoparticle transfection reagent for In Vivo Delivery. These innovative products beneficial for high transfection efficiency, reproducibility and robustness approach for medical applications. It is also beneficial for a new business portfolio and raises market penetration.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Transfection Reagents market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Transfection Reagents market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Transfection Reagent Manufacturers, Transfection Reagent Provider, End-Use Market Participants of Different Segments of Transfection Reagent, Government and Research Organizations, R&D Institutions and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.